In summary, our study reveals that MEOX1 expression is upregulated following AMI and, as a downstream target of TGF-β1, MEOX1 can inhibit angiogenesis and promote cardiac fibrosis post-AMI in vitro via EndoMT induction. The gene discussed is TGFB1; the disease is fibrosis.